Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis
B. R. Yerxa, J. R. Sabater, C. W. Davis, M. J. Stutts, M. Lang-Furr, M. Picher, A. C. Jones, M. Cowlen, R. Dougherty, J. Boyer, W. M. Abraham and R. C. Boucher
Journal of Pharmacology and Experimental Therapeutics September 2002, 302 (3) 871-880; DOI: https://doi.org/10.1124/jpet.102.035485
B. R. Yerxa
J. R. Sabater
C. W. Davis
M. J. Stutts
M. Lang-Furr
M. Picher
A. C. Jones
M. Cowlen
R. Dougherty
J. Boyer
W. M. Abraham
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 302, Issue 3
1 Sep 2002
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis
B. R. Yerxa, J. R. Sabater, C. W. Davis, M. J. Stutts, M. Lang-Furr, M. Picher, A. C. Jones, M. Cowlen, R. Dougherty, J. Boyer, W. M. Abraham and R. C. Boucher
Journal of Pharmacology and Experimental Therapeutics September 1, 2002, 302 (3) 871-880; DOI: https://doi.org/10.1124/jpet.102.035485
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis
B. R. Yerxa, J. R. Sabater, C. W. Davis, M. J. Stutts, M. Lang-Furr, M. Picher, A. C. Jones, M. Cowlen, R. Dougherty, J. Boyer, W. M. Abraham and R. C. Boucher
Journal of Pharmacology and Experimental Therapeutics September 1, 2002, 302 (3) 871-880; DOI: https://doi.org/10.1124/jpet.102.035485
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement